Decline of Admission for Acute Coronary Syndromes and Acute Cardiovascular Conditions during COVID-19 Pandemic in Veneto Region.
COVID-19
acute coronary syndrome
epidemiology
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
30 08 2022
30 08 2022
Historique:
received:
28
07
2022
revised:
22
08
2022
accepted:
27
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
Background: The present study aimed to examine longitudinal trends in hospitalizations for acute coronary syndrome (ACS) before and during the COVID-19 pandemic, by reviewing the data from 13 hospitals of the Veneto Region, in the north-east of Italy. Methods: We performed a multicenter, retrospective analysis including all the consecutive patients presenting with ACS and other acute cardiovascular (CV) conditions (defined as heart failure, arrhythmias, cardiac arrest and venous thromboembolism) hospitalized in 13 different hospitals of the Veneto Region covering a population of 2,554,818 inhabitants, during the first (between 15 March 2020 and 30 April 2020) and second (between 15 November 2020 and 30 December 2020) COVID-19 pandemic waves (the 2020 cohort). Data were compared with those obtained at the same time-windows of years 2018 and 2019 (the historical cohorts). Results: Compared to the historical cohorts, a significant decrease in the number of ACS cases was observed in 2020 (−27.3%, p = 0.01 and −32%, p < 0.001, comparing 2018 versus 2020 and 2019 and 2020, respectively). The proportion of patients hospitalized for acute CV conditions decreased during the first and second wave COVID-19 pandemic when compared to the historical cohorts (−36.5%, p < 0.001 and −40.6%, p < 0.001, comparing 2018 versus 2020 and 2019 and 2020, respectively). Pearson’s correlation evidenced a significant inverse relationship between the number of COVID-19 cases and both ACS hospital admissions (r = −0.881, p = 0.005) and hospitalizations for acute CV conditions (r = −0.738, p = 0.01), respectively. Conclusions: The decrease in hospitalizations for ACS and other acute CV conditions will strongly affect future patients’ management since undiagnosed nonfatal CV events represent a source of increased (and unknown) CV morbidity and mortality.
Identifiants
pubmed: 36146731
pii: v14091925
doi: 10.3390/v14091925
pmc: PMC9502380
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Références
J Am Coll Cardiol. 2020 Jul 21;76(3):280-288
pubmed: 32470516
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
J Am Heart Assoc. 2020 Jul 7;9(13):e017122
pubmed: 32441548
Z Gesundh Wiss. 2022;30(8):1985-1993
pubmed: 35004128
Eur Heart J. 2019 May 21;40(20):1590-1596
pubmed: 30860255
Clin Res Cardiol. 2020 Dec;109(12):1500-1506
pubmed: 32749557
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):439-445
pubmed: 34173942